Kali sulphuricum

Kali sulphuricum is an FDA drug label for the active ingredient POTASSIUM SULFATE manufactured by Boiron administered by ORAL. This page reproduces the FDA-approved indications and usage, dosage, contraindications, warnings, and adverse reactions exactly as published in the drug label. Data source: openFDA (U.S. FDA), label effective 20231113.

Generic: POTASSIUM SULFATE

Manufacturer: Boiron

Product Type: HUMAN OTC DRUG

Route: ORAL

Dosage Form:

NDC: 0220-2975

Application:

Effective: 20231113

Active Ingredients: Kali sulphuricum 12C (**contains 0.443 mg of the active ingredient per pellet)

Indications & Usage

Colds With Yellow Nasal Discharge*

Dosage & Administration

Adults and children: At the onset of symptoms, dissolve 5 pellets under the tongue 3 times a day until symptoms are relieved or as directed by a doctor.

Contraindications

Not available.

Warnings

Not available.

Adverse Reactions

Not available.

More from same ingredient

KALI SULPH

Hyland's Inc.